Home » Lifestyle » Health » Covid-19 Death Toll Hits 5,437 as 1,667 More Test Positive

Covid-19 Death Toll Hits 5,437 as 1,667 More Test Positive

by Zablon Ondari
2 mins read

The Ministry of Health has confirmed 1,667 new Covid-19 cases, bringing the country’s caseload to 310,797.

The new cases were detected from 8,703 samples tested. This has raised the cumulative tests to 3,094,153. The Covid-19 positivity rate stands at 19.2 per cent.

In a press statement issued in Nairobi on 8th January, Health CS Mutahi Kagwe said that from the new cases, 1,462 are Kenyans while 205 are foreigners with 840 being males while 827 females. The youngest is a one-month-old infant while the oldest is 110.

Kagwe said 2,523 patients have recovered from the disease, 2,395 from the Home-Based Isolation and Care programme while 128 are from various health facilities. The total number of recoveries now stands at 264,656.

The national death toll rose to 5,437 after 12 more patients succumbed to the virus.

Currently, there are 1,210 patients admitted to various health facilities countrywide, while 25,991 are under the Home-Based Isolation and Care programme. 

Some 54 patients are in the Intensive Care Unit (ICU), 31 of them on ventilatory support while 22 are on supplemental oxygen. One patient is under observation.

Another 316 patients are on supplemental oxygen, 288 of them are in the general wards and 28 patients are in the High Dependency Unit (HDU).

Vaccination: As of 7th January 2022, a total of 10,572,187 vaccines had so far been administered across the country. Of these, 6,030,173 are partially vaccinated while those fully vaccinated are 4,468,661.

Another 24,010 are doses administered to those between 15 to 18 years while 49,393 are booster doses.

The uptake of the second dose among those who received their first dose was at 56.7 per cent. Proportion of adults fully vaccinated was 16.4 per cent. The Government is working towards vaccinating a targeted population of 27,246,033.

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More